The neuropeptide galanin is a 29- or 30-residue peptide whose physiological functions aremediated by G-protein-coupled receptors. Galanin's agonist activity has been shown to be associatedwith the N-terminal sequence, galanin(1-16). Conformational investigations previously carried out onfull-length galanin have, furthermore, indicated the presence of a helical conformation in the neuropeptide'sN-terminal domain. Several cyclic lactam analogues of galanin(1-16)-NH
2 were prepared in an attemptto stabilize an N-terminal helix in the peptide. Here we describe
and compare the solution conformationalproperties of these analogues in the presence of SDS micelles as determined by NMR, CD,
and fluorescencespectroscopy. Differences in CD spectral profiles were observed among the compounds that were studied.Both c[D
4,K
8]Gal(1-16)-NH
2 and c[D
4,K
8]Gal(1-12)-NH
2 adopted stable helical conformations in themicelle solution. On the basis of the analyses of their respective
![](/images/gifchars/alpha.gif)
H chemical shifts
and NOE patterns,this helix was localized to the first 10 residues. The distance between the aromatic rings of Trp
2 and Tyr
9in c[D
4,K
8]Gal(1-16)-NH
2 was determined to be 10.8 ± 3 Å from fluorescence resonance energy transfermeasurements. This interchromophore spacing was found to be more consistent with a helical structurethan an extended one. Removal of the Gly
1 residue in compounds c[D
4,K
8]Gal(1-16)-NH
2 and c[D
4,K
8]Gal(1-12)-NH
2 resulted in a loss of helical conformation
and a concomitant reduction in binding potencyat the
GalR1 receptor but not at the Ga
lR2 receptor. The nuclear Overhauser enhancements obtained forthe Gly
1 deficient analogues did, however, reveal the presence of nascent helical structures within theN-terminal sequence. Decreasing the ring structure size in c[D
4,K
8]Gal(1-16)-NH
2 by replacing Lys
8with an ornithine residue or by changing the position of the single lysine residue from eight to seven wasaccompanied by a complete loss of helical structure
and dramatically reduced receptor affinity. It isconcluded from the data obtained for the series of cyclic galanin(1-16)-NH
2 analogues that both the ringstructure size
and the presence of an N-terminal glycine residue are important for stablilizing an N-terminalhelix in these compounds. However, although an N-terminal helix constitutes a predominant portion ofthe conformational ensemble for compounds c[D
4,K
8]Gal(1-16)-NH
2 and c[D
4,K
8]Gal(1-12)-NH
2, thesepeptides nevertheless are able to adopt other conformations in solution. Consequently, the correlationbetween the ability of the cyclic galanin analogues to adopt an N-terminal helix
and bind to the GalR1receptor may be considered as a working hypothesis.